RU94046434A - Новые пептиды, способ их получения и их применение - Google Patents

Новые пептиды, способ их получения и их применение

Info

Publication number
RU94046434A
RU94046434A RU94046434/04A RU94046434A RU94046434A RU 94046434 A RU94046434 A RU 94046434A RU 94046434/04 A RU94046434/04 A RU 94046434/04A RU 94046434 A RU94046434 A RU 94046434A RU 94046434 A RU94046434 A RU 94046434A
Authority
RU
Russia
Prior art keywords
synthesis
new peptides
application
peptides
new
Prior art date
Application number
RU94046434/04A
Other languages
English (en)
Other versions
RU2116312C1 (ru
Inventor
Хаупт Андреас
De]
Эмлинг Франц
Ромердаль Синтия
Us]
Original Assignee
БАСФ Акциенгезельшафт (DE)
Басф Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by БАСФ Акциенгезельшафт (DE), Басф Акциенгезельшафт filed Critical БАСФ Акциенгезельшафт (DE)
Publication of RU94046434A publication Critical patent/RU94046434A/ru
Application granted granted Critical
Publication of RU2116312C1 publication Critical patent/RU2116312C1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Предлагаются новые пептиды формулы I, в которой R, R, A, B, D, E, F, G, K, X, t, u, v и w имеют значения, приведенные в описании, и их получение. Новые вещества обладают антинеопластическим эффектом.

Claims (1)

  1. Предлагаются новые пептиды формулы I, в которой R1, R2, A, B, D, E, F, G, K, X, t, u, v и w имеют значения, приведенные в описании, и их получение. Новые вещества обладают антинеопластическим эффектом.
RU94046434A 1992-05-20 1993-05-10 Производные пептида или их соли, фармацевтическая композиция RU2116312C1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US88578892A 1992-05-20 1992-05-20
US07/885.788 1992-05-20
US98569692A 1992-11-25 1992-11-25
US07/985.696 1992-11-25

Publications (2)

Publication Number Publication Date
RU94046434A true RU94046434A (ru) 1996-10-27
RU2116312C1 RU2116312C1 (ru) 1998-07-27

Family

ID=27128772

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94046434A RU2116312C1 (ru) 1992-05-20 1993-05-10 Производные пептида или их соли, фармацевтическая композиция

Country Status (21)

Country Link
EP (1) EP0642530B1 (ru)
JP (2) JP3523253B2 (ru)
KR (1) KR100286242B1 (ru)
CN (1) CN1065874C (ru)
AT (1) ATE169637T1 (ru)
AU (1) AU669710B2 (ru)
CA (1) CA2136339C (ru)
CZ (1) CZ292612B6 (ru)
DE (1) DE69320339T2 (ru)
DK (1) DK0642530T3 (ru)
ES (1) ES2118955T3 (ru)
FI (1) FI120692B (ru)
HU (2) HUT71398A (ru)
IL (1) IL105651A (ru)
MX (1) MX9302927A (ru)
NO (1) NO310465B1 (ru)
NZ (1) NZ252147A (ru)
RU (1) RU2116312C1 (ru)
SI (1) SI9300267A (ru)
UA (1) UA45304C2 (ru)
WO (1) WO1993023424A1 (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
DE4415997A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neuer peptidischer Wirkstoff und dessen Herstellung
DE4415998A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neue Tetrapeptide, ihre Herstellung Verwendung
DE19527574A1 (de) * 1995-07-28 1997-01-30 Basf Ag Verfahren zur Herstellung vona-(N,N-Dialkyl)-aminocaarbonsäureamiden
DE19527575A1 (de) * 1995-07-28 1997-01-30 Basf Ag Verfahren zur Herstellung von peptidischer Wirkstoffe
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
AU775090B2 (en) * 1995-12-15 2004-07-15 Abbvie Deutschland Gmbh & Co Kg Antineoplastic peptides
US20010009901A1 (en) 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US5741892A (en) * 1996-07-30 1998-04-21 Basf Aktiengesellschaft Pentapeptides as antitumor agents
US5939527A (en) * 1996-07-30 1999-08-17 Basf Aktiengesellschaft Tetrapeptides as antitumor agents
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6143721A (en) 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
WO1999015130A2 (en) * 1997-09-24 1999-04-01 ARIZONA BOARD OF REGENTS, actingon behalf of ARIZ ONA STATE UNIVERSITY Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
US6686445B1 (en) 1997-09-24 2004-02-03 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
ATE415413T1 (de) 2002-07-15 2008-12-15 Univ Princeton Iap-bindende verbindungen
ATE412409T1 (de) 2003-11-24 2008-11-15 Teva Gyogyszergyar Zartkoeruee Verfahren zur reinigung von pravastatin
WO2023033129A1 (ja) 2021-09-03 2023-03-09 東レ株式会社 癌の治療及び／又は予防用医薬組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
ATE190983T1 (de) * 1991-08-09 2000-04-15 Teikoku Hormone Mfg Co Ltd Neue tetrapeptidderivate

Also Published As

Publication number Publication date
KR100286242B1 (ko) 2001-04-16
IL105651A0 (en) 1993-09-22
HU211745A9 (en) 1995-12-28
NO944419D0 (no) 1994-11-18
CN1065874C (zh) 2001-05-16
FI945416A0 (fi) 1994-11-17
AU669710B2 (en) 1996-06-20
CZ284394A3 (en) 1995-05-17
DK0642530T3 (da) 1998-10-26
CN1085563A (zh) 1994-04-20
EP0642530B1 (en) 1998-08-12
JPH07506580A (ja) 1995-07-20
HUT71398A (en) 1995-11-28
RU2116312C1 (ru) 1998-07-27
IL105651A (en) 1998-07-15
SI9300267A (sl) 1993-12-31
WO1993023424A1 (en) 1993-11-25
CA2136339A1 (en) 1993-11-25
NO944419L (no) 1995-01-09
EP0642530A1 (en) 1995-03-15
JP3523253B2 (ja) 2004-04-26
DE69320339T2 (de) 1998-12-17
NZ252147A (en) 1996-10-28
NO310465B1 (no) 2001-07-09
CZ292612B6 (cs) 2003-11-12
MX9302927A (es) 1993-11-01
FI945416A (fi) 1994-11-17
ES2118955T3 (es) 1998-10-01
DE69320339D1 (de) 1998-09-17
UA45304C2 (uk) 2002-04-15
ATE169637T1 (de) 1998-08-15
AU4066293A (en) 1993-12-13
FI120692B (fi) 2010-01-29
JP2004149538A (ja) 2004-05-27
CA2136339C (en) 2008-02-05

Similar Documents

Publication Publication Date Title
RU94046434A (ru) Новые пептиды, способ их получения и их применение
BR1100019A (pt) Peptìdeo, compostos, composição farmacêutica, e, método de preparar compostos
CY1112274T1 (el) Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν
RU93048636A (ru) 7-/замещенные/-8-/замещенные/-9-/замещенные амино/-6-диметил-6-дезокситетрациклины, промежуточные соединения, способы получения соединений, способ профилактики и лечения и фармацевтическая композиция
RU93055882A (ru) Производные n-сульфонил-2-оксоиндола, способ их получения, исходные для их получения, фармацевтическая композиция на их основе
CA2219818A1 (en) Novel compounds, the preparation and use thereof
CA2338600A1 (en) Novel thiazolopyrimidine compounds
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
RU95101833A (ru) Косметические или фармацевтические композиции, включающие липосомы, и способ их получения
RU94035964A (ru) Производные бензопирана, фармацевтическая композиция на их основе, способ их получения, способ лечения и способ получения промежуточного продукта
CA2094806A1 (en) Aminosulfonyl urea acat inhibitors
IT1230483B (it) Procedimento per la produzione di una proteina endotossica, gene strutturale impiegato e composizioni insetticide comprendenti detta proteina
NO964688D0 (no) Ny peptid-aktivsubstans og fremstilling av denne
MY114327A (en) Novel peptides, the preparation and use thereof
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
GR1000098B (el) Παραγωγα διοξαζοκινης, παρασκευη των και συνθεσεις που τα περιεχουν.
RU93056617A (ru) Ингибиторы ретровирусной протеазы, способ их получения, промежуточные продукты, способ лечения и фармацевтическая композиция
RU93045696A (ru) Ингибиторы протеазы вируса иммунодефицита человека, полезные для лечения спида
IT8821384A0 (it) 5 pirimidincarbossamidi sostituite e composizioni farmaceutiche contenenti le stesse per il trattamento di leucemia.
CA2195663A1 (en) Dihydrobenzofuranes
RU93004708A (ru) Производные замещенного пирролидина и их терапевтически приемлемые соли, способ их получения и фармацевтическая композиция
IT8522247A0 (it) Camera per l'essiccazione di paste alimentari e prodotti analoghi.
ITMI922215A1 (it) Derivato di mentile procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono